Improving Medicare’s policies for separately payable drugs in the hospital outpatient prospective payment system (1)

The Congress should direct the Secretary to modify the pass-through drug policy in the hospital outpatient prospective payment system so that it:

• includes only drugs and biologics that function as supplies to a service and
• applies only to drugs and biologics that are clinically superior to their packaged analogs.